BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 187990)

  • 1. Serum 17 alpha-hydroxyprogesterone in patients with gestational trophoblastic neoplasms.
    Osathanondh R; Goldstein DP; Tulchinsky D; Finn AE
    Obstet Gynecol; 1977 Jan; 49(1):77-9. PubMed ID: 187990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal measurements in patients with theca lutein cysts and gestational trophoblastic disease.
    Osathanondh R; Berkowitz RS; de Cholnoky C; Smith BS; Goldstein DP; Tyson JE
    J Reprod Med; 1986 Mar; 31(3):179-83. PubMed ID: 3009803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural history of theca lutein cysts.
    Montz FJ; Schlaerth JB; Morrow CP
    Obstet Gynecol; 1988 Aug; 72(2):247-51. PubMed ID: 2455880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of ultrasound in the evaluation of trophoblastic disease and its response to therapy.
    Requard CK; Mettler FA
    Radiology; 1980 May; 135(2):419-222. PubMed ID: 6245429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nausea and vomiting of pregnancy: role of human chorionic gonadotropin and 17-hydroxyprogesterone.
    Soules MR; Hughes CL; Garcia JA; Livengood CH; Prystowsky MR; Alexander E
    Obstet Gynecol; 1980 Jun; 55(6):696-700. PubMed ID: 7383455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum testosterone and dihydrotestosterone in patients with trophoblastic disease.
    Dawood MY; Saxena BB
    Obstet Gynecol; 1976 Jun; 47(6):684-8. PubMed ID: 180465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma prolactin, progesterone, estradiol, and human chorionic gonadotropin in complete and partial moles before and after evacuation.
    Ho PC; Wong LC; Ma HK
    Obstet Gynecol; 1986 Jan; 67(1):99-106. PubMed ID: 3940346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose methotrexate for gestational trophoblastic disease.
    Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
    Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and outcome of healthy women with a persistently elevated beta-hCG.
    Palmieri C; Dhillon T; Fisher RA; Young AM; Short D; Mitchell H; Aghajanian C; Savage PM; Newlands ES; Hancock BW; Seckl MJ
    Gynecol Oncol; 2007 Jul; 106(1):35-43. PubMed ID: 17482245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human chorionic gonadotropin, its free subunits and gestational trophoblastic disease.
    Ozturk M
    J Reprod Med; 1991 Jan; 36(1):21-6. PubMed ID: 1706779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum progesterone for the exclusion of early pregnancy in women at risk for recurrent gestational trophoblastic neoplasia.
    Rodriguez GC; Hughes CL; Soper JT; Berchuck A; Clarke-Pearson DL; Hammond CB
    Obstet Gynecol; 1994 Nov; 84(5):794-7. PubMed ID: 7936514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum free estriol and estriol glucuronide fractions in hydatidiform mole measured by radioimmunoassay.
    Dawood MY; Brown JB; Newnam KL
    Obstet Gynecol; 1977 Mar; 49(3):303-7. PubMed ID: 840458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M; el-Shobokshy AS; el-Noury AI
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of complete and partial molar pregnancy.
    Goldstein DP; Berkowitz RS
    J Reprod Med; 1994 Mar; 39(3):139-46. PubMed ID: 8035368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of beta-subunit chorionic gonadotropin as an aid in diagnosis of trophoblastic disease.
    Skinner MS; Seckinger D
    Ann Clin Lab Sci; 1979; 9(4):347-52. PubMed ID: 225983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.